Related Experiment Videos
New aliphatic nitro-compounds from Indigofera carlesii
Xin-Xin Zhang1, Zhen-Xia Zhang, Lei Chen
1College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin, 300072, PR China. pleasantzxx@sohu.com
Fitoterapia
|November 2, 2005
Summary
Two novel aliphatic nitro-compounds were identified in Indigofera carlesii. These compounds, 2-O-acryl-3,6-di-O-(3-nitropropanoyl)-alpha-d-glucopyranose and 6-O-acryl-2,3-di-O-(3-nitropropanoyl)-alpha-d-glucopyranose, were characterized using spectral analysis.
Area of Science:
- Natural Product Chemistry
- Organic Chemistry
- Phytochemistry
Background:
- Indigofera carlesii is a plant species known for its potential bioactive compounds.
- Aliphatic nitro-compounds represent a class of organic molecules with diverse chemical properties.
- Previous research on Indigofera species has revealed various secondary metabolites.
Purpose of the Study:
- To investigate the chemical constituents of Indigofera carlesii, specifically focusing on aliphatic nitro-compounds.
- To isolate and identify novel compounds from this plant species.
- To elucidate the structures of the newly identified compounds.
Main Methods:
- Extraction and isolation of chemical compounds from Indigofera carlesii.
- Spectroscopic techniques (e.g., NMR, Mass Spectrometry) for structural elucidation.
- Chromatographic methods for compound purification.
Main Results:
- Identification of two novel blended aliphatic nitro-compounds.
- The identified compounds are 2-O-acryl-3,6-di-O-(3-nitropropanoyl)-alpha-d-glucopyranose and 6-O-acryl-2,3-di-O-(3-nitropropanoyl)-alpha-d-glucopyranose.
- Structural characterization was achieved through comprehensive spectral analysis.
Conclusions:
- The study successfully identified and characterized two new aliphatic nitro-compounds from Indigofera carlesii.
- These findings contribute to the understanding of the phytochemical diversity of Indigofera species.
- The elucidated structures provide a basis for further investigation into the biological activities of these novel compounds.